Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Corporate Insiders Point to Three Stocks Poised to Explode

Page 1 of 2

The Standard & Poor’s 500 Index and the Nasdaq Composite Index closed in the red on Friday, mainly prompted by the slumping biotech stocks (i.e. the Nasdaq Biotech Index lost 6.2%). However, most U.S. equities bounced back during the week’s last trading session, after the Fed Chair, Janet Yellen, suggested a high probability of a rate hike this year. Janet Yellen’s speech on Thursday seems to have assured market participants that the strength of the US economy will most likely allow it to tackle higher interest rates. Frankly speaking, it is hard to find a rationale in the recent swings in stock markets (some market participants find it hard to assess the effects of a potential rate hike). However, some corporate executives have started to show confidence in the prospects of their companies as well by bolstering their holdings. The Insider Monkey team identified notable insider buying activity at Apogee Enterprises Inc. (NASDAQ:APOG), Five Below Inc. (NASDAQ:FIVE), and Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP). Therefore, this article will discuss some potential explanations behind insiders’ moves, which might point to some trading opportunities.

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 118% over the ensuing 36 months, outperforming the S&P 500 Index by nearly 61 percentage points (read more details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Let’s kick off our discussion by examining the insider activity at Apogee Enterprises Inc. (NASDAQ:APOG). Joseph F. Puishys, who has acted as Chief Executive Officer and President since 2011, purchased 11,000 shares last Friday at a weighted average price of $46.11 apiece. Hence, the executive enlarged his holding to 238,423 shares valued at $11.07 million, which also includes restricted stock awards. The shares of Apogee have plummeted by nearly 20% since it released its fiscal 2016 second-quarter results on September 16, which suggests that either the executive is buying shares on weakness or he just wants to persuade market participants to stop beating down Apogee’s stock. The company’s revenues increased by 4% year-over-year to $240.8 million, while its earnings per share were up 45% to $0.50. However, the market did not like that Apogee revised down its revenue growth outlook for the full year to 10% from 15%. Donald Chiboucis’ Columbus Circle Investors enlarged its stake in Apogee Enterprises Inc. (NASDAQ:APOG) during the second quarter to roughly 341,000 shares.

Follow Apogee Enterprises Inc. (NASDAQ:APOG)
Trade (NASDAQ:APOG) Now!
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!